An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVENTM in Subjects With Cancer Who Also Have Impaired Renal Function
This study is currently recruiting participants.
Verified June 2013 by Eisai Inc.
Information provided by (Responsible Party):
First received: August 1, 2011
Last updated: June 6, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||No date given|
|Estimated Primary Completion Date:||August 2013 (Final data collection date for primary outcome measure)|